清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

Stable incidence and survival of arteriovenous fistulas over 39 years: A long-term national cohort study

医学 期限(时间) 入射(几何) 外科 队列 内科学 人口学 动静脉瘘 数学 几何学 量子力学 物理 社会学
作者
Kristine Lindhard,Ditte Hansen,Brian Pedersen,Marianne Rix,Henrik Post Hansen,Boye L. Jensen,James Heaf
出处
期刊:Journal of Vascular Access [SAGE Publishing]
卷期号:24 (4): 620-629 被引量:2
标识
DOI:10.1177/11297298211046102
摘要

INTRODUCTION: The age and number of comorbidities in the hemodialysis population has increased over time. This may influence the construction and survival of the arteriovenous fistula (AVF). The present study explored the incidence and survival of AVFs over a period of 39 years. METHODS: A retrospective cohort study was conducted based on Danish registries. Incident hemodialysis patients between 1977 and 2015 were included. The incidence of AVF and factors associated with the construction of an AVF were described. Risk factors for AVF survival and repair were explored by Kaplan Meier and Cox proportional hazard analysis. RESULTS: The total number of arteriovenous accesses (AVF and arteriovenous grafts) were 10,187 and there were 4201 central venous catheters (CVC). No significant difference in the proportion of AVFs during the 39 years was seen. Age and renal diagnosis did not influence the proportion of AVFs. Patients with CVCs were found to have a significantly higher prevalence of comorbidities ( p < 0.01). AVF survival remained stable during the 39 years. The first constructed AVF had the best survival, 35% still functioning after 15 years. Factors such as brachiocephalic AVF, female sex, and diabetic nephropathy increased the risk of AVF failure (Odds Ratio (OR): 2.46, 95% Confidence Interval (CI) (2.29-2.65), 1.17 (1.10-1.25), and 1.21 (1.12-1.3)), respectively. CONCLUSION: Despite an older dialysis population, the proportion and survival of the AVF in the Danish dialysis population has not changed, probably because of increased awareness of AVF as the first choice of vascular access and improved surveillance, surgery, and repair.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
19秒前
23秒前
Charming完成签到,获得积分10
24秒前
Charming发布了新的文献求助10
29秒前
1分钟前
zsyf发布了新的文献求助10
1分钟前
Kinkin完成签到,获得积分10
1分钟前
DarknessDuck发布了新的文献求助10
1分钟前
纪靖雁完成签到 ,获得积分10
1分钟前
zsyf完成签到,获得积分10
1分钟前
molihuakai应助DarknessDuck采纳,获得10
2分钟前
2分钟前
谢锦印完成签到,获得积分10
2分钟前
2分钟前
谢锦印发布了新的文献求助10
2分钟前
欣欣发布了新的文献求助10
2分钟前
mzhang2完成签到 ,获得积分10
2分钟前
玩命的寄翠完成签到 ,获得积分10
2分钟前
勤劳觅风完成签到,获得积分10
3分钟前
儒雅的夏翠完成签到,获得积分10
3分钟前
呆萌如容完成签到,获得积分10
3分钟前
科研通AI2S应助铭铭采纳,获得10
4分钟前
胡萝卜完成签到,获得积分10
5分钟前
5分钟前
铭铭发布了新的文献求助10
5分钟前
香蕉觅云应助铭铭采纳,获得10
5分钟前
标致的满天完成签到 ,获得积分10
5分钟前
Phiephie发布了新的文献求助10
5分钟前
5分钟前
铭铭发布了新的文献求助10
6分钟前
机灵自中完成签到,获得积分10
6分钟前
Seriously完成签到,获得积分10
6分钟前
FashionBoy应助铭铭采纳,获得10
6分钟前
欣喜的香菱完成签到 ,获得积分10
6分钟前
Cm666应助Xenomorph采纳,获得10
7分钟前
桐桐应助科研通管家采纳,获得10
7分钟前
Orange应助科研通管家采纳,获得10
7分钟前
7分钟前
7分钟前
铭铭发布了新的文献求助10
7分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
The Cambridge History of China: Volume 4, Sui and T'ang China, 589–906 AD, Part Two 1500
Cowries - A Guide to the Gastropod Family Cypraeidae 1200
Quality by Design - An Indispensable Approach to Accelerate Biopharmaceutical Product Development 800
Signals, Systems, and Signal Processing 610
Research Methods for Applied Linguistics 500
A Social and Cultural History of the Hellenistic World 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 物理 内科学 复合材料 催化作用 物理化学 光电子学 电极 细胞生物学 基因 无机化学
热门帖子
关注 科研通微信公众号,转发送积分 6394582
求助须知:如何正确求助?哪些是违规求助? 8209714
关于积分的说明 17382316
捐赠科研通 5447800
什么是DOI,文献DOI怎么找? 2880027
邀请新用户注册赠送积分活动 1856542
关于科研通互助平台的介绍 1699160